Tus%25252525252525252525252525252525252525252525252525252520qd

## Overview Tus%25252525252525252525252525252525252525252525252525252520qd is a combination medication containing guaifenesin and dextromethorphan. Guaifenesin is an expectorant that helps loosen mucus in the airways. Dextromethorphan is a cough suppressant that acts on the cough center in the brain. ## Primary Indications * Relief of cough associated with the common cold, bronchitis, or other respiratory conditions. * Loosening of mucus. ## Adult Dosing * **Guaifenesin:** 200-400 mg every 4 hours as needed. Maximum 2400 mg daily. * **Dextromethorphan:** 10-20 mg every 4 hours as needed, or 30 mg every 6-8 hours as needed. Maximum 120 mg daily. * *Note: Specific dosing for Tus%25252525252525252525252525252525252525252525252525252520qd formulations will vary. Always consult the product labeling for the specific strengths and recommended dosages.* ## Pediatric Dosing Dosing for pediatric patients varies significantly by age and product formulation. Consult specific product labeling or a pediatric dosing reference for age-appropriate recommendations. Generally, use is not recommended for children under 6 years of age without physician guidance. ## Dose Adjustments No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised in patients with severe impairment. ## Contraindications * Hypersensitivity to guaifenesin or dextromethorphan. * Use within 14 days of MAOI therapy (for dextromethorphan component). * Use in children under 6 years of age without physician guidance. ## Adverse Effects * **Common:** Nausea, vomiting, dizziness, drowsiness, rash. * **Less Common:** Headache, confusion, constipation, abdominal pain. * **Rare:** Respiratory depression (especially with overuse or in combination with other CNS depressants). ## Key Drug Interactions * **MAOIs and other serotonergic agents:** Increased risk of serotonin syndrome with dextromethorphan. * **CNS Depressants (e.g., alcohol, sedatives, opioids):** Increased risk of drowsiness and respiratory depression. * **CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine):** May increase dextromethorphan levels. ## Monitoring * Monitor for cough relief and expectorant effect. * Assess for adverse effects, particularly drowsiness and signs of CNS depression. * Monitor for potential drug interactions, especially in patients taking other CNS-active medications or MAOIs. ## Clinical Pearls * Ensure adequate hydration to aid in the effectiveness of guaifenesin. * Dextromethorphan can cause abuse or misuse in higher than recommended doses. * Product formulations vary widely; always verify the exact strengths and dosage instructions. *** *This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant literature before making any clinical decisions. Dosing and recommendations may vary based on patient-specific factors and local protocols.*